NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,391,372 | +146161.3% | 330,300 | +33.1% | 0.00% | +50.0% |
| Q1 2023 | $1,635 | -55.1% | 248,100 | -30.0% | 0.00% | -60.0% |
| Q4 2022 | $3,645 | -100.0% | 354,600 | +35.8% | 0.01% | -77.3% |
| Q2 2022 | $13,538,000 | -39.1% | 261,102 | -12.1% | 0.02% | -24.1% |
| Q1 2022 | $22,216,000 | -63.9% | 297,203 | -25.2% | 0.03% | -60.3% |
| Q4 2021 | $61,534,000 | -29.7% | 397,431 | -7.6% | 0.07% | -26.3% |
| Q3 2021 | $87,553,000 | +1.7% | 430,171 | +4.4% | 0.10% | -25.6% |
| Q2 2021 | $86,124,000 | +55.8% | 412,196 | +29.3% | 0.13% | +60.2% |
| Q1 2021 | $55,272,000 | +43.8% | 318,906 | -1.3% | 0.08% | +38.3% |
| Q4 2020 | $38,449,000 | +28.8% | 323,214 | +16.8% | 0.06% | -17.8% |
| Q3 2020 | $29,860,000 | +82.3% | 276,612 | +41.2% | 0.07% | +65.9% |
| Q2 2020 | $16,377,000 | +499.7% | 195,873 | +2.6% | 0.04% | +388.9% |
| Q1 2020 | $2,731,000 | – | 190,958 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |